Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
about
Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to dateEpigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.Binimetinib for the treatment of NRAS-mutant melanoma.A review of binimetinib for the treatment of mutant cutaneous melanoma.Targeted agents and immunotherapies: optimizing outcomes in melanoma.Ipilimumab in melanoma.What have we learned from cancer immunotherapy in the last 3 years?Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma.An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.Cutaneous melanoma: From pathogenesis to therapy (Review).Biomarkers for Immune Checkpoint Inhibitors in Melanoma
P2860
Q33887664-C75F1705-0CDB-4463-89B9-D8D6B9C23B26Q37694816-EB9165B2-7FB4-4C0E-B7B4-861D2F33AEC3Q38636033-2A933D49-0BA4-4EE0-B2AF-1C4B6462B152Q38674107-A5F0F7FE-6730-4480-B7DE-B86C65154828Q38856722-06F84692-FB9C-4A31-A11D-0B1739136807Q38893697-173C5A55-ED42-4195-AF4A-9EEC75670752Q40065733-2BB07358-88FD-4785-9A65-0069E60E7A87Q42369277-954CF704-A758-47C3-87C4-0AB85DD03731Q50923886-09E9A382-5DD2-4251-B39B-B3CF7724FB5DQ51746622-E266A94F-3597-4A1A-B251-408B1341E7B5Q52658584-631D1283-C337-4DBE-B836-C5BC1F42E472Q57175477-EFF9460D-8254-4FC6-BA7A-A382EADF6BF5
P2860
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@ast
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@en
type
label
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@ast
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@en
prefLabel
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@ast
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@en
P2093
P2860
P1433
P1476
Analysis of BRAF and NRAS Muta ...... ciation with Overall Survival?
@en
P2093
Anna L Frauchiger
Axel Hauschild
Benjamin Weide
Christoph Hoeller
Emanuella Romano
Holger Moch
Joanna Mangana
Katharina C Kähler
Katja Schindler
Markus Rechsteiner
P2860
P304
P356
10.1371/JOURNAL.PONE.0139438
P407
P577
2015-10-01T00:00:00Z